Search Results - "Ladislau, L"

Malaria in Brazil: an overview by Oliveira-Ferreira, Joseli, Lacerda, Marcus V G, Brasil, Patrícia, Ladislau, José L B, Tauil, Pedro L, Daniel-Ribeiro, Cláudio Tadeu

“…Malaria is still a major public health problem in Brazil, with approximately 306,000 registered cases in 2009, but it is estimated that in the early 1940s,…”
Get full text

A Comparison of Eleven Static Heuristics for Mapping a Class of Independent Tasks onto Heterogeneous Distributed Computing Systems by Braun, Tracy D, Siegel, Howard Jay, Beck, Noah, Bölöni, Ladislau L, Maheswaran, Muthucumaru, Reuther, Albert I, Robertson, James P, Theys, Mitchell D, Yao, Bin, Hensgen, Debra, Freund, Richard F

“…Mixed-machine heterogeneous computing (HC) environments utilize a distributed suite of different high-performance machines, interconnected with high-speed…”
Get full text

In vitro activation of type I interferon pathway reproduces the characteristics damages observed in dermatomyositis patients by Ladislau, L, Suárez-Calvet, X, Toquet, S, Benjamim, C, Mouly, V, Boutler-Browne, G, Benveniste, O, Allenbach, Y

Get full text

Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in Amazon basin communities by Santelli, Ana C, Ribeiro, Isabela, Daher, André, Boulos, Marcos, Marchesini, Paola B, dos Santos, Roseli La Corte, Lucena, Marize B F, Magalhães, Izanelda, Leon, Antonio P, Junger, Washington, Ladislau, José L B

“…Studies in South-East Asia have suggested that early diagnosis and treatment with artesunate (AS) and mefloquine (MQ) combination therapy may reduce the…”
Get full text

EPH218 The Clinical and Economic Epidemiology of Breast Cancer in Brazil from 2016 to 2022: A Real-World Evidence Study of 295,000 Outpatients in Public System by Costa e Silva, M, Silva, J, Santos, L, Huerta, CDM, Madeira, LR, Resende, H, Ladislau, L

Get full text

P.196 - In vitro activation of type I interferon pathway reproduces the characteristics damages observed in dermatomyositis patients by Ladislau, L., Suárez-Calvet, X., Toquet, S., Benjamim, C., Mouly, V., Boutler-Browne, G., Benveniste, O., Allenbach, Y.

Get full text

PB2281 BIOSIMILAR TRIALS IN DEVELOPING COUNTRIES: FINAL RESULTS OF AN ACTION PLAN TO DETECT AND ERADICATE BARRIERS TO PATIENT RECRUITMENT by Castilho, V., Ladislau, L., Paula, M. I. D., Alcântara, A., Gimenez, L., Bueno, M. M.

“…Background: The development of biosimilar drugs requires a strong comparability exercise and also a phase 3 head‐to‐head trial to show no differences between…”
Get full text

PB2281 BIOSIMILAR TRIALS IN DEVELOPING COUNTRIES: FINAL RESULTS OF AN ACTION PLAN TO DETECT AND ERADICATE BARRIERS TO PATIENT RECRUITMENT by Castilho, V., Ladislau, L., Paula, M. I. D., Alcântara, A., Gimenez, L., Bueno, M. M.

Get full text

Les inhibiteurs de la voie des Janus-kinases : un traitement prometteur de la dermatomyosite pour inhiber de la voie de l’interféron by Toquet, S., Landon-Cardinal, O., Guillaume-Jugnot, P., Champtiaux, N., Ladislau, L., Suárez-Calvet, X., Amelin, D., Stenzel, W., Rigolet, A., Hervier, B., Benveniste, O., Allenbach, Y.

“…Les dermatomyosites (DM) sont des pathologies chroniques invalidantes (atteintes musculaires et cutanées) pouvant engager le pronostic vital (atteinte…”
Get full text

L’activation in vitro de la voie interféron de type I reproduit les lésions caractéristiques observées chez les patients atteints de dermatomyosite by Toquet, S., Ladislau, L., Suárez-Calvet, X., Rozenberg, F., Stenzel, W., Benjamin, C., Mouly, V., Butler-Browne, G., Benveniste, O., Allenbach, Y.

“…Les interférons de type I (IFN-I) qui incluent l’IFN-α et l’IFN-β sont des cytokines clés impliquées dans la réponse immunitaire innée aux infections virales…”
Get full text